Blossomhill Therapeutics discovers new EGFR mutant inhibitors

FierceBiotechFoundation Medicine tallies FDA nod to pair its blood test with Pfizer’s prostate cancer combo

FierceBiotechNew heights for NewLimit as anti-aging biotech nabs $435M to rejuvenate old cells

Endpoints NewsLilly gives hospitals deadline to comply with 340B claims data policy

Endpoints NewsFDA details flexibilities for new cell and gene therapies to leverage past data

Endpoints NewsAnti-aging biotech NewLimit raises $435M at $3B+ valuation

BioPharma DiveEli Lilly issues data sharing ultimatum to 340B hospitals

FierceBiotechASCO: Roche, head held high, details oral SERD's first-line flop in breast cancer

BioPharma DiveFulcrum exploring a potential sale after FDA sidelined its sickle cell drug

Endpoints NewsWhat’s next for VEGF? #ASCO26 offered clues, but answers will have to wait

BioWorldLongbio to raise HK$1.4B in Hong Kong IPO for immunology work

BioWorldADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal

BioWorldChina launches long-awaited drug data protection rules